For research and laboratory use only. Not for human consumption. Sold only to persons aged 18 and over.

Back to lexicon

Triple agonist GIP/GLP-1/glucagon

Retatrutide

Overview

Retatrutide is an investigational peptide binding three receptors of the incretin and glucagon system simultaneously.

Retatrutide targets three receptors simultaneously and is the subject of intensive preclinical research.

Research areas

Multi-receptor pharmacologyEnergy balance models

Compound data

Formula
C221H342N46O68
Molar mass
4731,3 g/mol
CAS no.
2381089-83-2
Purity
≥ 99 %

Literature & databases

  • PubMed: retatrutide

All information is provided for scientific purposes only. It does not constitute any claim regarding use, dosage or effect.